Admissions and credentials

New York

Experience

LB Pharmaceuticals Announces $285 Million Upsized IPO

September 12, 2025

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Minkyu Park
Special Counsel, New York
Denny Xu
Associate, Boston
Danbi Kim
Associate, Boston
Ariane A. Andrade
Partner, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Karun Ahuja
Special Counsel, Chicago
Brandon Lefebvre
Quantitative Analyst, Boston
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Gerard O'Shea
Partner, New York
David Peinsipp
Partner, San Francisco
Ryan Vann
Partner, Chicago
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jessica Koffel
Special Counsel, Brussels
Rebecca Ross
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Chelsea Braun
Associate, Boston
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Vince Flynn
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Brenna McGuire
Associate, Washington, DC
Sarah Miller
Associate, New York
Jayne M. Munger
Associate, New York
Miles Patton
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Cathy Rude
Paralegal Specialist, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Shoulder Innovations Announces $75 Million IPO

July 31, 2025

Cooley advised the underwriters of Shoulder Innovations, a medical technology company exclusively focused on transforming the shoulder surgical care market, in connection with Shoulder Innovations’ $75 million initial public offering (IPO).

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Scott Weston
Partner, Boston
Kassity L. Mai
Special Counsel, Reston
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Valerie Sapozhnikova
Associate, Los Angeles
Alex Hammer
Associate, San Francisco
Allison Kutner
Associate, New York
Sunny J. Levine
Associate, Colorado
Ryan Lewis
Associate, Colorado
Sarah Miller
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Aardvark Therapeutics Announces $94.2 Million IPO

February 14, 2025

Cooley advised the underwriters of Aardvark Therapeutics, a phase 3 biotech company developing novel small-molecule therapies for metabolic diseases, in connection with Aardvark’s $94.2 million initial public offering (IPO).

Read more

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
Denny Won
Partner, San Francisco
Jean Park
Partner, New York
Christine Turner
Associate, Colorado
Ryan Lewis
Associate, Colorado
Joanna Zhang
Associate, San Diego
Lila Hope
Partner, Palo Alto
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Zack Gong
Associate, Shanghai
Tony P. Guan
Associate, Santa Monica
Sarah Miller
Associate, New York

Related Practices & Industries

Beta Bionics Announces Upsized $234.6 Million IPO, Concurrent $17 Million Private Placement

January 31, 2025

Cooley represented Beta Bionics, a pioneering leader in the development of advanced diabetes management solutions, in its $234.6 million initial public offering and concurrent $17 million private placement.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Mark Weeks
Partner, Palo Alto
Charlie Kim
Partner, San Diego
Christine S. Kim
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Sarah Miller
Associate, New York
Jessica Koffel
Special Counsel, Brussels
Thomas Welk
Senior Counsel, San Diego
Dani Nazemian
Special Counsel, San Diego
Ross Eberly
Partner, Santa Monica
Joanna Liebes Hubberts
Partner, San Diego
Alexandra Paterson
Associate, London
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Michael Egan
Partner, Washington, DC
Tania Soris
Associate, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Francis Wheeler
Senior Counsel, Colorado

Related Practices & Industries

Avid Bioservices Announces $1.1 Billion Acquisition by GHO Capital Partners and Ampersand Capital Partners

November 6, 2024

Cooley advised Avid Bioservices (Nasdaq: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, on its definitive merger agreement to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion.

Read more

Related contacts

Bill Sorabella
Partner, New York
Natalie D. Vernon
Associate, Colorado
Sarah Buchik
Associate, New York
Patrick Reed
Associate, Palo Alto
Alexis Johnson
Associate, Boston
David Silverman
Partner, New York
Barbara Mirza
Partner, Santa Monica
Austin Holt
Partner, Santa Monica
Tony P. Guan
Associate, Santa Monica
Howard Morse
Senior Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Sarah Miller
Associate, New York
Eileen Marshall
Partner, Washington, DC
Todd Gluth
Partner, San Diego
Calvin Lee
Associate, New York
Christophe Beauduin
Partner, New York
Charity Williams
Partner, San Diego
Jameson Davis
Associate, Boston
Koji Fukumura
Partner, San Diego
Peter Adams
Partner, San Diego
Michael Egan
Partner, Washington, DC
Ellie Seber
Partner, Santa Monica
Alexandra Leavy
Associate, New York
Timothy Nguyen
Special Counsel, San Francisco
Justin Kisner
Special Counsel, San Diego
Christopher Kimball
Partner, Washington, DC
Shelby Saunders
Associate, New York
Ross Eberly
Partner, Santa Monica
Joshua Elefant
Associate, Palo Alto
Alanna B Zuchelli
Special Counsel, Reston
Leanne Andrepont
Senior Trademark Paralegal
Megan Boss
Senior Paralegal , Boston

Related Practices & Industries

Memberships and affiliations

American Health Law Association (AHLA)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.